Editorial: Quantitative [18F]NaF PET in metastatic and metabolic bone diseases
Tanuj Puri,
Tanuj Puri,
Amelia E. Moore,
Abhishek Mahajan,
Alan McWilliam,
Marie H. Vrist,
Glen M. Blake
Affiliations
Tanuj Puri
Faculty of Biology, Medicine and Health, School of Medical Sciences, Division of Cancer Sciences, The University of Manchester, The Christie NHS Foundation Trust, Manchester, United Kingdom
Tanuj Puri
Department of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King’s College London, St. Thomas’ Hospital, London, United Kingdom
Amelia E. Moore
Department of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King’s College London, St. Thomas’ Hospital, London, United Kingdom
Abhishek Mahajan
The Clatterbridge Cancer Centre NHS Foundation Trust, University of Liverpool, Liverpool, United Kingdom
Alan McWilliam
Faculty of Biology, Medicine and Health, School of Medical Sciences, Division of Cancer Sciences, The University of Manchester, The Christie NHS Foundation Trust, Manchester, United Kingdom
Marie H. Vrist
Gødstrup Hospital, University Clinic in Nephrology and Hypertension, Herning, Denmark
Glen M. Blake
Department of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King’s College London, St. Thomas’ Hospital, London, United Kingdom
